Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Rezolute, Inc. Director's Dealing 2013

Feb 9, 2013

32362_dirs_2013-02-08_380692c9-0c56-40e8-9b4d-4ec2c293c049.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: AntriaBio, Inc. (ANTB)
CIK: 0001509261
Period of Report: 2013-01-31

Reporting Person: Kukekov Nickolay (Director)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 2392000 Direct
Common Stock 1597074 Indirect

Footnotes

F1: Dr. Kukekov owns 2,392,000 shares of common stock of the Issuer.

F2: Dr. Kukekov is a non-controlling member of Chromium 24, LLC, a Delaware limited liability company. Dr. Kukekov does not have voting or dispositive power with respect to the shares of the Issuer's common stock held by Chromium 24, LLC. Dr. Kukekov disclaims beneficial ownership of the shares of the Issuer's common stock held by Chromium 24, LLC except to the extent of his pecuniary interest therein.